Bo-shi Zhang

Chiba, 2608670, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes.

Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes.

Journal: Endocrine journal

Published: July 22, 2026

Anti-GIP antibodies and future diabetes related risk: an eight-year prospective cohort study.

Anti-GIP antibodies and future diabetes related risk: an eight-year prospective cohort study.

Journal: Frontiers in endocrinology

Published: February 15, 2026

Increased autoantibodies against incretin indicate poor prognosis in patients with diabetes.

Increased autoantibodies against incretin indicate poor prognosis in patients with diabetes.

Journal: Scientific reports

Published: May 14, 2025

Application of serum anti-ENO1 and anti-SSNA1 antibody biomarkers in predicting the prognosis of gastric cancer.

Application of serum anti-ENO1 and anti-SSNA1 antibody biomarkers in predicting the prognosis of gastric cancer.

Journal: Oncology letters

Published: December 06, 2024

Plasma autoantibodies as novel risk markers for stroke: A nested case-control study of the JPHC study.

Plasma autoantibodies as novel risk markers for stroke: A nested case-control study of the JPHC study.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: November 29, 2024

Stage-Specific Alteration and Prognostic Relationship of Serum Fumarate Hydratase Autoantibodies in Gastric Cancer.

Stage-Specific Alteration and Prognostic Relationship of Serum Fumarate Hydratase Autoantibodies in Gastric Cancer.

Journal: International journal of molecular sciences

Published: April 10, 2024

JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.

JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.

Journal: International journal of molecular sciences

Published: March 15, 2024

Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases.

Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases.

Journal: Medicine international

Published: March 13, 2024

Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma.

Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma.

Journal: Cancer science

Published: January 18, 2024

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.

Journal: BMC endocrine disorders

Published: February 11, 2023

Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease.

Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease.

Journal: Medicine international

Published: September 22, 2022

Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer.

Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer.

Journal: Frontiers in cardiovascular medicine

Published: September 12, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026